Sort
3,198 grants matching “mrna vaccine”
Research Project 2: Antigen design and immunological evaluation
$1,758,323Steven Bradfute · Albert Einstein College Of Medicine · U19 · FY2024 · AI
Antigen Processing And Presentation In The Intestine
$1,757,182Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Influenza Viral Pathogenesis
$1,748,193Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern - LC Repository
$1,748,110Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2023 · AI
Nucleic acid-based vaccine for HIV and other indications
$1,725,137Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Discovery of Adjuvants that Direct T-cell Fates for Improved Safety and Efficacy in Vaccines Against Influenza and Tuberculosis
$1,724,791Aaron Esser-Kahn · University Of Chicago · N01 · FY2025 · AI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$1,724,205Pamela J Bjorkman · California Institute Of Technology · P01 · FY2024 · AI
Phase 1 study of a SARS-CoV-2 vaccine adjuvanted via controlled biodistribution of mRNA encoding spike protein and IL-12p70
$1,673,641David James Dowling · Boston Children'S Hospital · U01 · FY2025 · AI
Genomic profiling of influenza infections to identify biomarkers of disease severity
$1,666,018Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins
$1,665,552Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Immunotherapy of low grade lymphoid malignancies
$1,663,921Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$1,655,505Pamela J Bjorkman · California Institute Of Technology · P01 · FY2025 · AI
Research Project 2: Antigen design and immunological evaluation
$1,649,403Steven Bradfute · Albert Einstein College Of Medicine · U19 · FY2025 · AI
Project 2 - GMP Manufacturing of mRNA Immunogens
$1,625,932Thomas N Denny · Duke University · U19 · FY2019 · AI
Human papillomavirus (HPV) infection and cervical and anal cancers
$1,620,520Nicolas Wentzensen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Rapid Development of Vaccines for Emerging Viruses
$1,604,857Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Prevention of AIDS
$1,593,708Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Vaccine Treatment Evaluation Units(VTEU) mRNA-1273-P204 Moderna Pediatric
$1,585,845Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI
Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs
$1,582,499Leonidas A Stamatatos · Fred Hutchinson Cancer Center · U19 · FY2024 · AI
Natural History of HPV Infection to Neoplasia
$1,580,769Anna-Barbara None Moscicki · University Of California, San Francisco · R37 · FY2009 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$1,570,973Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
DNA Vaccines
$1,570,101George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Human papillomavirus (HPV) infection and cervical and anal cancers
$1,566,706Nicolas Wentzensen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
DNA Vaccines
$1,560,936George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Structure-Function Studies of the HIV-1 Envelope Glycoproteins
$1,549,551Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI